UDCA treatment reduces biliary tract cancer in primary sclerosing cholangitis

Ursodeoxycholic acid treatment correlated with reduced mortality, need for liver transplantation and biliary tract cancer in patients with primary sclerosing cholangitis, according to a presenter at The Liver Meeting Digital Experience.“UDCA was likely to be associated with a reduction with biliary tract cancer but not consistently significant, partly due to small sample size,” Toshihiko Arizumi, MD, an assistant professor in the department of internal medicine at Teikyo University School of Medicine, said during his presentation.Arizumi and colleagues identified 325 patients withRead More

Share on facebook
Share on twitter
Share on linkedin